CN109350696A - A kind of Chinese medicine preparation and preparation method thereof assisting in the treatment of coronary heart disease - Google Patents
A kind of Chinese medicine preparation and preparation method thereof assisting in the treatment of coronary heart disease Download PDFInfo
- Publication number
- CN109350696A CN109350696A CN201811426662.XA CN201811426662A CN109350696A CN 109350696 A CN109350696 A CN 109350696A CN 201811426662 A CN201811426662 A CN 201811426662A CN 109350696 A CN109350696 A CN 109350696A
- Authority
- CN
- China
- Prior art keywords
- parts
- heart disease
- coronary heart
- extra large
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 39
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 238000011282 treatment Methods 0.000 title claims abstract description 13
- 244000189799 Asimina triloba Species 0.000 claims abstract description 15
- 235000006264 Asimina triloba Nutrition 0.000 claims abstract description 15
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 15
- 241000756943 Codonopsis Species 0.000 claims abstract description 15
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 15
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 15
- 241000270288 Gekko Species 0.000 claims abstract description 15
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 15
- 241000772413 Lutrogale perspicillata Species 0.000 claims abstract description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 15
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 15
- 241001415846 Procellariidae Species 0.000 claims abstract description 15
- 210000003056 antler Anatomy 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 241000804384 Cynomorium songaricum Species 0.000 claims abstract description 14
- 241000501113 Sargentodoxa cuneata Species 0.000 claims abstract description 14
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 13
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims description 24
- 239000003390 Chinese drug Substances 0.000 claims description 18
- 239000012141 concentrate Substances 0.000 claims description 18
- 238000007789 sealing Methods 0.000 claims description 12
- 238000009098 adjuvant therapy Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 210000004907 gland Anatomy 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000014659 low sodium diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000037891 myocardial injury Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- -1 nitrate esters Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of Chinese medicine preparations and preparation method thereof for assisting in the treatment of coronary heart disease, including consisting of part: herba taxilli: 5-10g, pawpaw: 2-7g, ramulus mori: 200-300g, Radix Codonopsis: 2-5g, gekko: 10-20g, extra large five-pointed star: 8-15g, cynomorium songaricum: 8-10g, ganoderma lucidum: 10-15g, the fruit of glossy privet: 5-10g, Rhizoma Gastrodiae: 5-10g, Radix Notoginseng: 5-10g, extra large money: 1-5g, sargentodoxa cuneata: 30-70g, petrel: 1-5g, sea otter: 1-5g, fructus lycii: 8-15g, pilose antler: 1-5g, safflower: 1-3g.The advantages that Chinese medicinal preparation method that the present invention assists in the treatment of coronary heart disease is simple, and formula has effect good, quick, at low cost.
Description
Technical field
The invention belongs to the field of Chinese medicines, and in particular to a kind of Chinese medicine preparation and preparation method for assisting in the treatment of coronary heart disease.
Background technique
Coronary atherosclerotic heart disease, abbreviation coronary heart disease are that Atheromatosis occurs for coronary artery
Become and cause lumen of vessels stenosis or occlusion, causes heart disease caused by myocardial ischemia, anoxic or necrosis, commonly referred to as " hat
Heart trouble ".But the range of coronary heart disease may further include more extensively that inflammation, embolism etc. lead to luminal stenosis or occlusion.World health
Coronary heart disease is divided into 5 major class: silent ischemia (latent coronary heart disease), angina pectoris, myocardial infarction, ischemic mental and physical efforts by tissue
5 kinds of Clinical types of failure and sudden death.Usually it is divided into stable coronary heart disease and acute coronary syndrome in clinic.
The diagnosis of coronary heart disease relies primarily on typical clinical symptoms, finds that myocardial ischemia or coronary artery hinder in conjunction with auxiliary examination
The evidence and myocardial injury markers of plug determine whether there is myocardial necrosis.It was found that the most common inspection method packet of myocardial ischemia
Include routine electrocardiogram and electrocardiogram stress test, Nuclear Cardiac Imaging.Invasive inspection has coronarography and intravascular super
Sound etc..But but normal coronary angiogram cannot negate coronary heart disease completely.
The treatment of coronary heart disease includes: that 1. living habit changes: smoking cessation limit wine, low-fat low-salt diet, appropriate physical training, control
Weight processed etc.；2. drug therapy: antithrombotic (antiplatelet, anticoagulant) mitigates myocardium keto consumption (beta-blocker), alleviates the heart and twists
(nitrate esters) bitterly adjust rouge to stablize patch (Statins fat regulation medicine)；3. revascularization is treated: including interventional therapy (intravascular ball
Capsule expands plasty and Stent) and surgery Coronary Artery Bypass Grafting.Drug therapy is the basis of all treatments.It is situated between
Enter and also to adhere to long-term standard medication therapy after surgical operation therapy.For same patient, in some of disease
Can ideally be controlled with drug when the stage, and be applied alone medication effect often bad at another stage, need by drug with
Interventional therapy or surgical operation share.
Summary of the invention
Aiming at the problems existing in the prior art, the present invention provide it is a kind of assist in the treatment of coronary heart disease Chinese medicine preparation and preparation
The advantages that method has effect good, quick, at low cost.
The technical solution adopted by the present invention: a kind of Chinese medicine preparation for treating osteoproliferation, including consisting of part: mulberry is posted
It is raw: 5-10 parts, pawpaw: 2-7 parts, ramulus mori: 200-300 parts, Radix Codonopsis: 2-5 parts, gekko: 10-20 parts, extra large five-pointed star: 8-15 parts, lock
Sun: 8-10 part, ganoderma lucidum: 10-15 part, the fruit of glossy privet: 5-10 parts, Rhizoma Gastrodiae: 5-10 parts, Radix Notoginseng: 5-10 parts, sea money: 1-5 parts, greatly
Blood rattan: 30-70 parts, petrel: 1-5 parts, sea otter: 1-5 parts, fructus lycii: 8-15 parts, pilose antler: 1-5 parts, safflower: 1-3 parts
It is preferred that treating the Chinese medicine preparation of osteoproliferation, including consisting of part: herba taxilli: 8 parts, pawpaw: 5 parts, mulberry
Branch: 250 parts, Radix Codonopsis: 5 parts, gekko: 20 parts, extra large five-pointed star: 10 parts, cynomorium songaricum: 10 parts, ganoderma lucidum: 12 parts, the fruit of glossy privet: 7 parts, Rhizoma Gastrodiae: 8
Part, Radix Notoginseng: 8 parts, extra large money: 3 parts, sargentodoxa cuneata: 50 parts, petrel: 3 parts, sea otter: 3 parts, fructus lycii: 10 parts, pilose antler: 2 parts, safflower:
2 parts.
The Chinese medicine preparation of present invention adjuvant treatment coronary heart disease: the following steps are included:
(1) mix: by formula weigh herba taxilli, pawpaw, ramulus mori, Radix Codonopsis, gekko, extra large five-pointed star, cynomorium songaricum, ganoderma lucidum, the fruit of glossy privet,
Rhizoma Gastrodiae, Radix Notoginseng, extra large money, sargentodoxa cuneata, petrel, sea otter, fructus lycii, pilose antler, safflower, are then uniformly mixed, obtain Traditional Chinese drug mixture；
(2) it impregnates: the 5-7 times of water measured is added in the resulting Traditional Chinese drug mixture of step (1), impregnates 30-60min；
(3) decoct: the Traditional Chinese drug mixture end after step (2) are impregnated decocts, and decocts 1-2h, decocts 2-3 times, merges
Decoction liquor；
(4) it is concentrated: decoction liquor obtained by step (3) being uniformly mixed with mixed liquor obtained by step (4), is concentrated under reduced pressure into opposite
Density is 1.15-1.25g/cm3, concentrate is collected, 12-24h is stood, it is spare；
(5) homogeneous: 1-2% honey is added after the resulting concentrate heating of step (5) is boiled, is uniformly mixed, and carry out
Homogeneous；
(6) filling: the concentrate after step (6) homogeneous is filtered, it is filling, it is distributed into bottle, gland sealing；
(7) it sterilizes: the medicine bottle of filling and sealing obtained by step (7) being packed into sterilizing cabinet, saturated vapor sterilizes, cold
But to get the traditional Chinese medicine oral liquid of the adjuvant treatment coronary heart disease.
The present invention is opposite reach with the prior art the utility model has the advantages that having the effect that
(1) it is raw material that the present invention, which selects natural plant, and using the comprehensive function of each taste Chinese medicine come prevention and treatment of coronary heart disease, nothing is appointed
What toxic side effect, and dependence will not be generated.
(2) Chinese medicine composition of the invention is turbid etc. for blood stasis, the deficiency of vital energy, phlegm from the traditional Chinese medicine angle because of stasis of blood detoxification
It demonstrate,proves marquis and the therapeutic effect of good prevention and treatment of coronary heart disease is reached using the therapy of promoting blood circulation, tonifying Qi, resolving sputum.
(3) by pharmacological evaluation and clinical observation, there are preferable effect, and difficulty in relapse after healing, short treating period to coronary heart disease.
Specific embodiment
Embodiment 1
The technical solution adopted by the present invention: the Chinese medicine preparation of osteoproliferation, including consisting of part: herba taxilli are treated:
8g, pawpaw: 5g, ramulus mori: 250g, Radix Codonopsis: 5g, gekko: 20g, extra large five-pointed star: 10g, cynomorium songaricum: 10g, ganoderma lucidum: 12g, the fruit of glossy privet: 7g,
Rhizoma Gastrodiae: 8g, Radix Notoginseng: 8g, extra large money: 3g, sargentodoxa cuneata: 50g, petrel: 3g, sea otter: 3g, fructus lycii: 10g, pilose antler: 2g, safflower:
2g。
The Chinese medicine preparation of present invention adjuvant treatment coronary heart disease: the following steps are included:
(1) mix: by formula weigh herba taxilli, pawpaw, ramulus mori, Radix Codonopsis, gekko, extra large five-pointed star, cynomorium songaricum, ganoderma lucidum, the fruit of glossy privet,
Rhizoma Gastrodiae, Radix Notoginseng, extra large money, sargentodoxa cuneata, petrel, sea otter, fructus lycii, pilose antler, safflower, are then uniformly mixed, obtain Traditional Chinese drug mixture；
(2) it impregnates: the resulting Traditional Chinese drug mixture of step (1) being added to the water of 5 times of amounts, impregnates 60min；
(3) decoct: the Traditional Chinese drug mixture end after step (2) are impregnated decocts, and decocts 1h, decocts 2 times, merges and decocts
Liquid；
(4) it is concentrated: decoction liquor obtained by step (3) being uniformly mixed with mixed liquor obtained by step (4), is concentrated under reduced pressure into opposite
Density is 1.20g/cm3, concentrate is collected, 12h is stood, it is spare；
(5) homogeneous: 1% honey is added after the resulting concentrate heating of step (4) is boiled, is uniformly mixed, and carry out equal
Matter；
(6) filling: the concentrate after step (5) homogeneous is filtered, it is filling, it is distributed into bottle, gland sealing；
(7) it sterilizes: the medicine bottle of filling and sealing obtained by step (6) being packed into sterilizing cabinet, saturated vapor sterilizes, cold
But to get the traditional Chinese medicine oral liquid of the adjuvant treatment coronary heart disease.
Embodiment 2
The technical solution adopted by the present invention: the Chinese medicine preparation of osteoproliferation, including consisting of part: herba taxilli are treated:
8g, pawpaw: 5g, ramulus mori: 250g, Radix Codonopsis: 5g, gekko: 20g, extra large five-pointed star: 10g, cynomorium songaricum: 10g, ganoderma lucidum: 12g, the fruit of glossy privet: 7g,
Rhizoma Gastrodiae: 8g, Radix Notoginseng: 8g, extra large money: 3g, sargentodoxa cuneata: 50g, petrel: 3g, sea otter: 3g, fructus lycii: 10g, pilose antler: 2g, safflower:
2g。
The Chinese medicine preparation of present invention adjuvant treatment coronary heart disease: the following steps are included:
(1) mix: by formula weigh herba taxilli, pawpaw, ramulus mori, Radix Codonopsis, gekko, extra large five-pointed star, cynomorium songaricum, ganoderma lucidum, the fruit of glossy privet,
Rhizoma Gastrodiae, Radix Notoginseng, extra large money, sargentodoxa cuneata, petrel, sea otter, fructus lycii, pilose antler, safflower, are then uniformly mixed, obtain Traditional Chinese drug mixture；
(2) it impregnates: the resulting Traditional Chinese drug mixture of step (1) being added to the water of 7 times of amounts, impregnates 60min；
(3) decoct: the Traditional Chinese drug mixture end after step (2) are impregnated decocts, and decocts 2h, decocts 3 times, merges and decocts
Liquid；
(4) it is concentrated: decoction liquor obtained by step (3) being uniformly mixed with mixed liquor obtained by step (4), is concentrated under reduced pressure into opposite
Density is 1.15g/cm3, concentrate is collected, is stood for 24 hours, it is spare；
(5) homogeneous: 2% honey is added after the resulting concentrate heating of step (4) is boiled, is uniformly mixed, and carry out equal
Matter；
(6) filling: the concentrate after step (5) homogeneous is filtered, it is filling, it is distributed into bottle, gland sealing；
(7) it sterilizes: the medicine bottle of filling and sealing obtained by step (6) being packed into sterilizing cabinet, saturated vapor sterilizes, cold
But to get the traditional Chinese medicine oral liquid of the adjuvant treatment coronary heart disease.
Embodiment 3
The technical solution adopted by the present invention: the Chinese medicine preparation of osteoproliferation, including consisting of part: herba taxilli are treated:
5g, pawpaw: 7g, ramulus mori: 200g, Radix Codonopsis: 5g, gekko: 20g, extra large five-pointed star: 15g, cynomorium songaricum: 10g, ganoderma lucidum: 15g, the fruit of glossy privet:
It is 10g, Rhizoma Gastrodiae: 10g, Radix Notoginseng: 5g, extra large money: 5g, sargentodoxa cuneata: 30g, petrel: 5g, sea otter: 5g, fructus lycii: 8g, pilose antler: 5g, red
Flower: 3g.
The Chinese medicine preparation of present invention adjuvant treatment coronary heart disease: the following steps are included:
(1) mix: by formula weigh herba taxilli, pawpaw, ramulus mori, Radix Codonopsis, gekko, extra large five-pointed star, cynomorium songaricum, ganoderma lucidum, the fruit of glossy privet,
Rhizoma Gastrodiae, Radix Notoginseng, extra large money, sargentodoxa cuneata, petrel, sea otter, fructus lycii, pilose antler, safflower, are then uniformly mixed, obtain Traditional Chinese drug mixture；
(2) it impregnates: the resulting Traditional Chinese drug mixture of step (1) being added to the water of 6 times of amounts, impregnates 50min；
(3) decoct: the Traditional Chinese drug mixture end after step (2) are impregnated decocts, and decocts 1.5h, decocts 2 times, merges and decocts
Boil liquid；
(4) it is concentrated: decoction liquor obtained by step (3) being uniformly mixed with mixed liquor obtained by step (4), is concentrated under reduced pressure into opposite
Density is 1.20g/cm3, concentrate is collected, 20h is stood, it is spare；
(5) homogeneous: 1.5% honey is added after the resulting concentrate heating of step (4) is boiled, is uniformly mixed, and carry out
Homogeneous；
(6) filling: the concentrate after step (5) homogeneous is filtered, it is filling, it is distributed into bottle, gland sealing；
(7) it sterilizes: the medicine bottle of filling and sealing obtained by step (6) being packed into sterilizing cabinet, saturated vapor sterilizes, cold
But to get the traditional Chinese medicine oral liquid of the adjuvant treatment coronary heart disease.
Embodiment 4
The technical solution adopted by the present invention: the Chinese medicine preparation of osteoproliferation, including consisting of part: herba taxilli are treated:
10g, pawpaw: 7g, ramulus mori: 300g, Radix Codonopsis: 3g, gekko: 15g, extra large five-pointed star: 10g, cynomorium songaricum: 9g, ganoderma lucidum: 15g, the fruit of glossy privet:
It is 10g, Rhizoma Gastrodiae: 10g, Radix Notoginseng: 5g, extra large money: 2g, sargentodoxa cuneata: 40g, petrel: 4g, sea otter: 3g, fructus lycii: 12g, pilose antler: 3g, red
Flower: 2g
The Chinese medicine preparation of present invention adjuvant treatment coronary heart disease: the following steps are included:
(1) mix: by formula weigh herba taxilli, pawpaw, ramulus mori, Radix Codonopsis, gekko, extra large five-pointed star, cynomorium songaricum, ganoderma lucidum, the fruit of glossy privet,
Rhizoma Gastrodiae, Radix Notoginseng, extra large money, sargentodoxa cuneata, petrel, sea otter, fructus lycii, pilose antler, safflower, are then uniformly mixed, obtain Traditional Chinese drug mixture；
(2) it impregnates: the resulting Traditional Chinese drug mixture of step (1) being added to the water of 7 times of amounts, impregnates 60min；
(3) decoct: the Traditional Chinese drug mixture end after step (2) are impregnated decocts, and decocts 1h, decocts 2 times, merges and decocts
Liquid；
(4) it is concentrated: decoction liquor obtained by step (3) being uniformly mixed with mixed liquor obtained by step (4), is concentrated under reduced pressure into opposite
Density is 1.15g/cm3, concentrate is collected, is stood for 24 hours, it is spare；
(5) homogeneous: 1% honey is added after the resulting concentrate heating of step (4) is boiled, is uniformly mixed, and carry out equal
Matter；
(6) filling: the concentrate after step (5) homogeneous is filtered, it is filling, it is distributed into bottle, gland sealing；
(7) it sterilizes: the medicine bottle of filling and sealing obtained by step (6) being packed into sterilizing cabinet, saturated vapor sterilizes, cold
But to get the traditional Chinese medicine oral liquid of the adjuvant treatment coronary heart disease.
Claims (3)
1. a kind of Chinese medicine preparation for assisting in the treatment of coronary heart disease, it is characterised in that: including consisting of part: herba taxilli: 5-10 parts,
Pawpaw: 2-7 parts, ramulus mori: 200-300 parts, Radix Codonopsis: 2-5 parts, gekko: 10-20 parts, extra large five-pointed star: 8-15 parts, cynomorium songaricum: 8-10 parts,
Ganoderma lucidum: 10-15 parts, the fruit of glossy privet: 5-10 parts, Rhizoma Gastrodiae: 5-10 parts, Radix Notoginseng: 5-10 parts, extra large money: 1-5 parts, sargentodoxa cuneata: 30-70
Part, petrel: 1-5 parts, sea otter: 1-5 parts, fructus lycii: 8-15 parts, pilose antler: 1-5 parts, safflower: 1-3 parts.
2. a kind of Chinese medicine preparation for assisting in the treatment of coronary heart disease according to claim 1, it is characterised in that: including consisting of
Part: herba taxilli: 8 parts, pawpaw: 5 parts, ramulus mori: 250 parts, Radix Codonopsis: 5 parts, gekko: 20 parts, extra large five-pointed star: 10 parts, cynomorium songaricum: 10 parts,
Ganoderma lucidum: 12 parts, the fruit of glossy privet: 7 parts, Rhizoma Gastrodiae: 8 parts, Radix Notoginseng: 8 parts, extra large money: 3 parts, sargentodoxa cuneata: 50 parts, petrel: 3 parts, sea otter: 3
Part, fructus lycii: 10 parts, pilose antler: 2 parts, safflower: 2 parts.
3. a kind of Chinese medicine preparation for assisting in the treatment of coronary heart disease according to claim 1, it is characterised in that: including following step
It is rapid:
(1) it mixes: weighing herba taxilli, pawpaw, ramulus mori, Radix Codonopsis, gekko, extra large five-pointed star, cynomorium songaricum, ganoderma lucidum, the fruit of glossy privet, day by formula
Fiber crops, Radix Notoginseng, extra large money, sargentodoxa cuneata, petrel, sea otter, fructus lycii, pilose antler, safflower, are then uniformly mixed, obtain Traditional Chinese drug mixture；
(2) it impregnates: the 5-7 times of water measured is added in the resulting Traditional Chinese drug mixture of step (1), impregnates 30-60min；
(3) decoct: the Traditional Chinese drug mixture end after step (2) are impregnated decocts, and decocts 1-2h, decocts 2-3 times, merges and decocts
Liquid；
(4) it is concentrated: decoction liquor obtained by step (3) being uniformly mixed with mixed liquor obtained by step (4), is concentrated under reduced pressure into relative density
For 1.15-1.25g/cm3, concentrate is collected, 12-24h is stood, it is spare；
(5) homogeneous: 1-2% honey is added after the resulting concentrate heating of step (5) is boiled, is uniformly mixed, and carry out homogeneous；
(6) filling: the concentrate after step (6) homogeneous is filtered, it is filling, it is distributed into bottle, gland sealing；
(7) it sterilizing: the medicine bottle of filling and sealing obtained by step (7) is packed into sterilizing cabinet, saturated vapor sterilizes, and it is cooling, i.e.,
Obtain the traditional Chinese medicine oral liquid of the adjuvant treatment coronary heart disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811426662.XA CN109350696A (en) | 2018-11-27 | 2018-11-27 | A kind of Chinese medicine preparation and preparation method thereof assisting in the treatment of coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811426662.XA CN109350696A (en) | 2018-11-27 | 2018-11-27 | A kind of Chinese medicine preparation and preparation method thereof assisting in the treatment of coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109350696A true CN109350696A (en) | 2019-02-19 |
Family
ID=65342890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811426662.XA Pending CN109350696A (en) | 2018-11-27 | 2018-11-27 | A kind of Chinese medicine preparation and preparation method thereof assisting in the treatment of coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109350696A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329911A (en) * | 2001-06-06 | 2002-01-09 | 孟祥红 | Health-care medicinal liquor |
| CN101780221A (en) * | 2010-03-19 | 2010-07-21 | 杨璧百 | Kidney-tonifying and yang-strengthening medicinal liquor preparation and preparation method thereof |
| CN103211974A (en) * | 2013-05-09 | 2013-07-24 | 雷家荃 | Medicinal liquor for improving immunity and application thereof |
| CN103356903A (en) * | 2013-07-02 | 2013-10-23 | 袁娟 | Edible wine used for reinforcing spleen and tonifying kidney and preparation method thereof |
| CN104758806A (en) * | 2015-03-07 | 2015-07-08 | 李传伟 | Decocted extract for treating coronary heart disease and preparation method thereof |
| CN108310173A (en) * | 2018-04-13 | 2018-07-24 | 冯维新 | A kind of Chinese medicine preparation of auxiliary treatment early-stage cancer and its preparation method of oral solution |
-
2018
- 2018-11-27 CN CN201811426662.XA patent/CN109350696A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329911A (en) * | 2001-06-06 | 2002-01-09 | 孟祥红 | Health-care medicinal liquor |
| CN101780221A (en) * | 2010-03-19 | 2010-07-21 | 杨璧百 | Kidney-tonifying and yang-strengthening medicinal liquor preparation and preparation method thereof |
| CN103211974A (en) * | 2013-05-09 | 2013-07-24 | 雷家荃 | Medicinal liquor for improving immunity and application thereof |
| CN103356903A (en) * | 2013-07-02 | 2013-10-23 | 袁娟 | Edible wine used for reinforcing spleen and tonifying kidney and preparation method thereof |
| CN104758806A (en) * | 2015-03-07 | 2015-07-08 | 李传伟 | Decocted extract for treating coronary heart disease and preparation method thereof |
| CN108310173A (en) * | 2018-04-13 | 2018-07-24 | 冯维新 | A kind of Chinese medicine preparation of auxiliary treatment early-stage cancer and its preparation method of oral solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101507765B (en) | Medicine for treating cerebrovascular disease and sequela thereof and preparation method thereof | |
| CN104758806A (en) | Decocted extract for treating coronary heart disease and preparation method thereof | |
| CN104069446A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN102631538B (en) | Traditional Chinese medicine for treating heart disease | |
| CN100488558C (en) | Medicament for treating heart disease and preparation process thereof | |
| CN105833229A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating myocardial infarction | |
| CN109350696A (en) | A kind of Chinese medicine preparation and preparation method thereof assisting in the treatment of coronary heart disease | |
| CN101721608A (en) | Chinese herbal medicine pill used for treating heart diseases | |
| CN105055967B (en) | A kind of complex health care product and preparation method with auxiliary hyperglycemic function | |
| CN103908490A (en) | Pure plant traditional Chinese medicinal preparation for treating myocardial infarction and cardiovascular diseases and preparation method thereof | |
| CN103301299B (en) | A kind of Chinese medicine composition improving Heart Function After Myocardial Infarction | |
| CN100396310C (en) | Medicine for treating coronary heart disease | |
| CN102908425A (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
| CN102430085A (en) | Chinese medicine for treating coronary heart disease | |
| CN106620253B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia | |
| CN110882347A (en) | A Chinese medicinal composition for treating cardiovascular diseases | |
| CN110339323A (en) | A kind of Chinese medicine composition and its preparation method and application for treating bradycardia | |
| CN105687962A (en) | Electuary capable of treating atherosclerosis of coronary artery and preparation method thereof | |
| CN104082670A (en) | Health porridge with effect of lowering blood pressure and production method thereof | |
| CN103638428A (en) | Traditional Chinese medicinal composition for treating coronary heart disease | |
| CN102716293A (en) | Capsule for treating hypertension, hyperlipemia, arteriosclerosis and coronary heart disease | |
| CN106421510A (en) | Medicine for treating atherosclerosis | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease | |
| CN105582303A (en) | Traditional Chinese medicine preparation for treating coronary heart disease | |
| CN104906311B (en) | A kind of traditional Chinese herbal decoction for treating diastolic heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190219 |
|
| RJ01 | Rejection of invention patent application after publication |